FitLife Brands vs Niagen Bioscience
Niagen Bioscience reported revenue of $129 million in fiscal 2025, 1.6 times FitLife Brands' $82 million in fiscal 2025. FitLife Brands' revenue grew 26.4% in its latest year, and Niagen Bioscience's grew 29.9%. FitLife Brands had an operating margin of 12.3%, against 12.6% at Niagen Bioscience.
Side by side
| FitLife Brands | Niagen Bioscience | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $82M | $129M |
| Revenue growth | 26.4% | 29.9% |
| Revenue growth a year, last 5 years | 30.3% | 16.9% |
| Gross margin | 38.6% | 64.3% |
| Operating margin | 12.3% | 12.6% |
| Net margin | 7.8% | 13.4% |
| Free cash flow | $7M | — |
| Free cash flow margin | 9.1% | — |
| Return on capital | — | — |
| Net debt to EBITDA | — | −3.8x |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 0.8% | 9.4% |
| Last close | $6.70 | $1.87 |
| P/E at the last close | 9.7× | 15.6× |
| Insider trades, last 12 months | bought $71,989, sold $0 | — |
| Piotroski F-score | — | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
FitLife BrandsNiagen Bioscience
Operating margin
Percent of revenue
FitLife BrandsNiagen Bioscience
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
FitLife BrandsNiagen Bioscience
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the FitLife Brands and Niagen Bioscience pages.